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Summary A case of Streptococcus pneumoniae meningitis in a possibly immune-compromised
child with a ventriculoatrial shunt is described. The infection was successfully eradicated by
treatment with intravenous ceftriaxone and rifampicin, without removal of the shunt.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
The recommended treatment for cerebrospinal fluid (CSF)
shunt infection is antibiotic administration with removal of
the shunt.1 The main pathogens of shunt infection are Sta-
phylococcus species.1 The pathogens that typically cause
meningitis in children (Haemophilus influenza type B, Strep-
tococcus pneumoniae and Neisseria meningitides) are rarely
implicated in CSF shunt infections. We describe a child with a
S. pneumoniae ventriculoatrial (VA) shunt infection and
meningitis who was treated successfully by antibiotics alone,
without the need to remove the shunt.
Case report
A 17-month-old female presented to our hospital with high
fever, vomiting, lethargy and apathy for a period of 72 hours.* Corresponding author. Department of Pediatrics C, Schneider
Children’s Medical Center of Israel, 14 Kaplan Street, Petach Tikva
49202, Israel. Tel.: +972 3 925 3775; fax: +972 3 925 3801.
E-mail address: yoji@netvision.net.il (E. Bilavsky).
1201-9712/$36.00 # 2008 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2008.07.008Amoxicillin 70 mg/kg/day had been prescribed by her pedia-
trician two days before hospital admission, without clinical
improvement. The parents also reported focal seizures on the
day of admission.
Pastmedical history revealedanormal-termpregnancy and
vaginal delivery. Two days after birth, a colonic perforation of
suspected intrauterine origin was detected and treated by
surgery with stoma placement. During hospitalization in the
neonatal intensive care unit, the child contracted Escherichia
coli sepsis followed by two episodes of E. colimeningitis. After
a protracted illness, a noncommunicating hydrocephalus was
diagnosedandaventriculo-peritoneal (VP) shuntwas inserted.
At the age of three months, the patient was readmitted with
bacteremiaand skin abscesses due toPseudomonas aeruginosa
infection; this was successfully treated with intravenous anti-
biotics. Onemonth later, aH. influenza VP shunt infection was
diagnosed. Treatment consisted of intravenous antibiotics and
shunt removal. Insertion of a new VP shunt failed due to
abdominal adhesions and a VA shunt was inserted. Given the
patient history, an extensive laboratory work-up was per-
formed for suspected immunodeficiency. The results yielded
normal-range levels of immunoglobulin, subtypes of IgG and
complement, normal neutrophil function, and normal B and TPublished by Elsevier Ltd. All rights reserved.
e102 K. Orvin et al.lymphocyte levels and function. Serology forHIVwas negative.
Colonoscopy ruled out the presence of a colonic fistula with
bacterial seeding.
At the most recent admission, notable findings upon
physical examination were a high temperature of 39.1 8C
and focal seizures. The seizures were controlled with phe-
nytoin and the patient was referred to the pediatric neuro-
surgery department for a shunt puncture. Because of the
small volume, the shunt fluid was sent only for bacterial
culture. Brain computed tomography showed normal-sized
ventricles. Treatment with vancomycin (50 mg/kg/day) and
ceftazidime (120 mg/kg/day) was initiated, and the patient
was transferred to our department of pediatrics.
At admission to the pediatric department, vital signs were
as follows: temperature 38.1 8C, heart rate 134 beats per
minute and blood pressure 112/49 mmHg. The patient
appeared pale, sleepy, irritable and apathetic. Neurological
evaluation revealed ‘sunset eyes’ with defects in upward
gaze and difficulty following objects. A complete blood count
revealed a white blood cell count of 10.8  109/l, with 35.5%
neutrophils and 47.2% lymphocytes. Hemoglobin measured
8.1 g/dl and the platelet count was 526 000/ml. Electrolyte
levels, and kidney and liver function tests were within the
normal range. A chest X-ray demonstrated a right upper lobe
infiltrate that was consistent with lobar pneumonia.
Blood and urine cultures taken on admission to the neu-
rosurgery department were sterile. The VA shunt fluid culture
obtained on the day of admission grew S. pneumoniaewith an
intermediate susceptibility to penicillin (a minimum inhibi-
tory concentration of 0.19 mg/ml) and susceptibility to cef-
triaxone, vancomycin and rifampicin. Antibiotic treatment
was therefore switched to ceftriaxone 100 mg/kg/day. A
lumbar puncture performed on the third day after admission
revealed a white blood cell count of 340 cells/mm3 (50%
segmented and 50% mononuclear), proteins 111.1 mg/dl and
glucose 43 mg/dl. Gram stain of the fluid was negative, but
culture grew S. pneumoniae with the same antibiogram as
the culture from the shunt puncture. Rifampicin (20 mg/kg/
day) was added to the ceftriaxone.
Two days later, the patient’s condition deteriorated,
manifesting as a high-pitched cry, right-hand weakness and
worsening in gaze. Magnetic resonance imaging showed bilat-
eral dilated ventricles. Echocardiography demonstrated a
thrombus blocking the end of the VA shunt. Treatment with
tissue plasminogen activator (0.8 mg/kg/hour) and enoxa-
parin (1 mg/kg/day) was initiated and led to substantial
clinical improvement. Repeated shunt and lumber puncture
cultures showed no bacterial growth. The patient was dis-
charged home after 16 days.
The patient remained well for the next three months,
when she was readmitted because of bacteremia and
extended-spectrum b-lactamase Klebsiella pneumoniae
shunt infection. She was treated with antibiotics, but this
time, owing to an increase in intracranial pressure, the shunt
was removed as well. A temporary shunt was inserted, which
was replaced three weeks later with a new VA shunt.
Discussion
Typical meningitis pathogens in children (H. influenza type B,
S. pneumoniae and N. meningitides) account for approxi-
mately 5% of all shunt infections2,3 and the incidence ofmeningitis caused by these organisms appears to be higher
in patients with a CSF shunt.2 Shunt infections with typical
meningitis pathogens have several unique characteristics.
They can occur long after shunt placement, unlike staphy-
lococcal infections, which usually occur within 2—6 months
(80% of patients). The route of invasion to the meninges is
usually hematogenous seeding (with retrograde infection),
rather than wound colonization at the time of surgery.3 Blood
cultures are communally positive.2
In this present case, the infection occurred more than one
year after shunt placement. Based on the early findings, we
suspect that the bacteria probably caused lobar pneumonia
initially and then, by hematogenous spread, meningitis. The
blood culture might have been negative because of the
amoxicillin treatment that was administered before the
patient’s admission to our department; the isolated pathogen
was moderately resistant to penicillin and the oral treatment
eradicated it from the blood. However, because of the low
CSF penetrability of amoxicillin, the pathogen persisted in
the meninges.
Of the various streptococcal species that cause meningi-
tis, S. pneumoniae is rarely implicated in shunt infections in
children. Our search of the English literature identified more
than 700 cases of shunt infection in which an etiologic agent
was identified, of which only 4 were due to S. pneumoniae.4—
10 However, uncommon culprits in shunt infection were
included in only a few reports and, even then, they were
categorized as ‘miscellaneous’. Therefore, the true inci-
dence could be somewhat higher. The specific characteristics
of these cases were not discussed.
Our patient had a significant history of serious bacterial
infection, raising the suspicion of an underlying immunode-
ficiency disease. However, our extensive immunological
investigation was noncontributory. We presume that an
undiagnosed immunodeficiency contributed to this rare case
of S. pneumoniae meningitis and to the other bacterial
infections.
Shunt infections are traditionally managed by antibiotic
administration and shunt removal. During the work-up in this
case, shunt removal was considered. However, given the
continuous positive response to ceftriaxone and rifampicin,
and the negative findings from repeated lumbar puncture and
shunt culture, we decided to keep the shunt in place. We
found only one other report of a similar case in the English
literature, wherein a six-month-old infant with S. pneumo-
niae meningitis and a VP shunt was successfully managed by
antibiotic treatment without shunt removal.11 Our decision
to add rifampicin to the pharmacologic regimen was based on
its high CSF penetration and favorable pharmacokinetics.12
We propose that S. pneumoniae shunt infection is more
amenable to antibiotic treatment alone because these
pathogens are less likely to adhere to the shunt lumen than
staphylococci.
In conclusion, although shunt removal should still be the
‘gold standard’ in most cases (regardless of organism) of
shunt infection in children, we suggest that, for Gram-posi-
tive non-staphylococcal infections when shunt removal is
difficult or impossible, clinicians could consider the use of
antibiotic treatment alone, without shunt removal.
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